{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:29:35Z","timestamp":1790749775537,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jad.2024.12.091","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T07:15:39Z","timestamp":1735197339000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1\u03b2 and interleukin-6 alongside hsCRP"],"prefix":"10.1016","volume":"373","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-6306","authenticated-orcid":false,"given":"Jae-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Seon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.12.091_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"16","key":"10.1016\/j.jad.2024.12.091_bb0010","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jpsychires.2010.04.011","article-title":"Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression","volume":"44","author":"Belzeaux","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jad.2024.12.091_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41398-019-0521-7","article-title":"Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies","volume":"9","author":"Carboni","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2024.12.091_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jad.2017.07.001","article-title":"Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks","volume":"233","author":"Gadad","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.12.091_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jad.2024.12.091_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.12.091_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.jad.2024.12.091_bb0040","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2024.12.091_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.30773\/pi.2017.10.2","article-title":"The MAKE biomarker discovery for enhancing anTidepressant treatment effect and response (MAKE BETTER) study: design and methodology","volume":"15","author":"Kang","year":"2018","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2024.12.091_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbi.2022.05.012","article-title":"Prospective associations of multimodal serum biomarkers with 12-week and 12-month remission in patients with depressive disorders receiving stepwise psychopharmacotherapy","volume":"104","author":"Kim","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.jad.2024.12.091_bb0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jad.2011.05.002","article-title":"Stressful events, stress perception and treatment outcomes in patients with depressive disorders: the CRESCEND study","volume":"133","author":"Kim","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.12.091_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jad.2020.05.002","article-title":"Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders","volume":"274","author":"Kim","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2024.12.091_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2024.12.091_bb0070","doi-asserted-by":"crossref","first-page":"pyw003","DOI":"10.1093\/ijnp\/pyw003","article-title":"Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms","volume":"19","author":"Martinotti","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.jad.2024.12.091_bb0075","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2024.12.091_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/dia.2006.8.28","article-title":"High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus","volume":"8","author":"Pfutzner","year":"2006","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jad.2024.12.091_bb0085","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2024.12.091_bb0090","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2024.12.091_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724020780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724020780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T09:59:32Z","timestamp":1738490372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724020780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":19,"alternative-id":["S0165032724020780"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.12.091","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing predictive accuracy for antidepressant response in depressive disorders: The additive value of interleukin-1\u03b2 and interleukin-6 alongside hsCRP","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.12.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}